03 December 2020>: Clinical Research
Development and Validation of Predictive Models for Vaginal Birth After Cesarean Delivery in China
Shilei Bi 1ACDEF* , Lizi Zhang 2ACDEF* , Jingsi Chen 134AC , Lijun Huang 1BF , Shanshan Zeng 1BF , Jinping Jia 5B , Suiwen Wen 6B , Yinli Cao 7B , Shaoshuai Wang 8B , Xiaoyan Xu 8B , Feng Ling 8B , Xianlan Zhao 9B , Yangyu Zhao 10B , Qiying Zhu 11B , Hongbo Qi 12B , Lanzhen Zhang 13B , Hongtian Li 14CD , Lili Du 134ACEG* , Zhijian Wang 2AG* , Dunjin Chen 134AG*DOI: 10.12659/MSM.927681
Med Sci Monit 2020; 26:e927681
Table 1 Maternal and neonatal outcomes.
Variables | Cesarean (n=129) | Vaginal birth (n=884) | P |
---|---|---|---|
24-h blood loss (mL) | 395 (300, 498) | 309.33 (265, 373.02) | 0 |
PPH | 4 (3.1%) | 68 (7.7%) | 0.065 |
Blood transfusion | 5 (3.9%) | 31 (3.5%) | 0.83 |
Rupture of uterus | 3 (2.3%) | 1 (0.1%) | 0.007 |
Injury of bladder | 0 | 14 (1.6%) | 0.237 |
Antibiotics after birth | 126 (97.7%) | 256 (29%) | 0 |
Oxytocin after birth | 124 (96.1%) | 801 (90.6) | 0.038 |
Prostaglandin after birth | 51 (39.5%) | 379 (42.9%) | 0.474 |
Ergonovine after birth | 6 (4.7%) | 22 (2.5%) | 0.155 |
Maternal mortality | 0 | 0 | |
1-min Apgar score | 9 (9, 10) | 9 (9, 10) | 0.16 |
Asphyxia | 3 (2.3%) | 28 (3.2%) | 0.105 |
Neonatal mortality | 1 (0.8%) | 0 | 1 |
PPH – postpartum hemorrhage. |